{"disease":{"id":"carcinosarcomas-uterine","name":"carcinosarcomas uterine"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02993705","title":"Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT03509207","title":"Vorinostat (SAHA) in Uterine Sarcoma","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"Medical University of Graz","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}